# Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism

> **NCT07688928** · NA · RECRUITING · sponsor: **Bangladesh Medical University** · enrollment: 104 (estimated)

## Conditions studied

- Primary Aldosteronism
- Endocrine Hypertension

## Interventions

- **DRUG:** Finerenone

## Key facts

- **NCT ID:** NCT07688928
- **Lead sponsor:** Bangladesh Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-03
- **Final completion:** 2027-09
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688928, "Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*